To recover your password please fill in your email address
Please fill in below form to create an account with us
Precision immunotherapies for multiple solid tumours using a biomarker driven adaptive enrichment clinical trials platform
The health economics team is leading a stream of research looking at the economics of biomarkers as diagnostic tests to identify those who will likely benefit from novel drug treatment.
The program will develop a Personalised Immunotherapy Program for people with melanoma and other cancers. It also includes a biomarker driven adaptive enrichment clinical trials platform.
|
Collaborators: |
Charles Perkins Centre and the Melanoma Institute Australia, University of Sydney |
|
Funded by: |
Cancer Institute NSW |
|
Chief investigators: |
Rachael L Morton, J Wilmott, G Long, Richard Scolyer, Michael Boyer, S Lo, A Menzies, I Silva, T Gide, AE Cust |
|
Contact: |